Komesaroff P A, Verity K, Fuller P J
Baker Medical Research Institute, Prahran, Victoria, Australia.
J Clin Endocrinol Metab. 1994 Jul;79(1):27-31. doi: 10.1210/jcem.79.1.8027241.
Mineralocorticoid resistance (pseudohypoaldosteronism) is a rare condition first described in 1958 and associated with failure to thrive, salt wasting, and dehydration in infancy. In the index case it has previously been shown that binding of aldosterone to mineralocorticoid receptors in peripheral blood lymphocytes is absent; here, we report results of the molecular characterization of the mineralocorticoid receptor in this patient. Genomic DNA extracted from peripheral blood lymphocytes was subjected to Southern blot analysis after digestion with various restriction enzymes. There was no evidence of a major gene rearrangement or deletion. Oligonucleotide primers were designed on the basis of the published human complementary DNA sequence to cover the entire open reading frame of the mineralocorticoid receptor (MR). Total messenger ribonucleic acid (RNA) from lymphocytes was subjected to reverse transcription and amplification using the reverse transcriptase-polymerase chain reaction; the resulting fragments were then purified, subcloned, and sequenced. The patient showed no abnormality in the complementary DNA sequence corresponding to the open reading frame of the MR molecule compared with the published sequence. In addition, semiquantitative assessment of the patient's MR messenger RNA based on the reverse transcriptase-polymerase chain reaction technique suggested that he was producing MR RNA in roughly normal quantities. The mechanism of mineralocorticoid resistance in this case, therefore, remains uncertain, and the possibility must be considered that the underlying abnormality is not in the MR gene, but in an independent gene acting through yet to be characterized processes.
盐皮质激素抵抗(假性醛固酮增多症)是一种罕见病症,于1958年首次被描述,与婴儿期生长发育迟缓、失盐和脱水有关。在首例病例中,先前已表明外周血淋巴细胞中醛固酮与盐皮质激素受体的结合缺失;在此,我们报告该患者盐皮质激素受体的分子特征研究结果。从外周血淋巴细胞中提取的基因组DNA用各种限制性内切酶消化后进行Southern印迹分析。没有证据表明存在主要基因重排或缺失。根据已发表的人类互补DNA序列设计寡核苷酸引物,以覆盖盐皮质激素受体(MR)的整个开放阅读框。淋巴细胞的总信使核糖核酸(RNA)使用逆转录 - 聚合酶链反应进行逆转录和扩增;然后将所得片段纯化、亚克隆并测序。与已发表序列相比,该患者在与MR分子开放阅读框相对应的互补DNA序列中未显示异常。此外,基于逆转录 - 聚合酶链反应技术对患者MR信使RNA的半定量评估表明,他产生的MR RNA量大致正常。因此,该病例中盐皮质激素抵抗的机制仍不确定,必须考虑潜在异常并非存在于MR基因中,而是存在于一个通过尚未明确的过程起作用的独立基因中的可能性。